Electromed, Inc. (ELMD) Fair Value 2026

ELMD · Electromedical & Electrotherapeutic Apparatus ·

By CirclFi Research Team · Data from SEC EDGAR, FRED & GDELT

Quality Score

9.4 /10

32 fundamental signals · 13 models active

Value Trap Risk

SAFE (22/100)

Quick Summary — As of 2026-07-13, Electromed, Inc. (ELMD) trades at $45.92, approximately 325% above CirclFi’s Bayesian DCF fair value of $10.81. QOC: 9.4/10. Value Trap Risk: 22/100 (SAFE). 13/13 models active.

Key Facts

Ticker
ELMD
Price
$45.92
Quality Score
9.4/10
Value Trap Risk
22/100
Models Active
13/13
Last Updated
Strength: Quality Score of 9.4/10 indicates strong fundamentals
Risk: Majority of models suggest overvaluation

Valuation Matrix

13 Intrinsic Value Models vs. Current Price ($45.92)

Core Models (Unlocked)
Model Fair Value Upside
Bayesian DCF
High Conviction
 $10.81 -76.5%
Earnings Power Value
High Conviction
 $6.91 -85.0%
CUCE Ensemble
Low Conviction
 $20.07 -56.3%
First Chicago
High Conviction
 $43.12 -6.1%

Unlock the Full Matrix

Access 9 additional models including EROIC Spread, Markov DDM, and more.

$1.30 / day

Billed monthly ($39/mo) or annually ($299/yr)

Unlock All 13 Models →

Cancel anytime · No contracts · Instant access

What Is Electromed, Inc. (ELMD) Worth in 2026?

According to the CirclFi Deep Alpha Valuation Engine, Electromed, Inc.'s intrinsic value is estimated at $32.75. Trading at its current price of $45.92, the valuation engine raises significant caution: 12 of 13 models flag downside risk, projecting an average implied return of -28.7%. Model dispersion is worth noting: Markov DDM targets $156.37 (+240.5%), versus Dynamic NAV at $5.22 (-88.6%). This +329.2% range highlights the importance of multi-model analysis rather than relying on any single methodology.

What Do the Models Say About ELMD?

13 of 13 models are currently active for ELMD. Of these, 1 model suggests upside while 12 models suggest overvaluation. The Bayesian DCF estimates ELMD's intrinsic value at $10.81, implying -76.5% downside from the current price. See which stocks rank higher →

How Does ELMD Rank in Electromedical & Electrotherapeutic Apparatus?

Among 25 Electromedical & Electrotherapeutic Apparatus stocks, ELMD ranks #2 by Quality of Company score. CirclFi's QOC score of 9.4/10 evaluates 32 fundamental signals. A score of 9.4 places ELMD in the top tier.

Electromed, Inc. operates in a competitive landscape where fundamental quality metrics are key differentiators for long-term value creation.

Is ELMD a Value Trap?

CirclFi's Value Trap algorithm assigns ELMD a score of 22/100 (SAFE). This indicates minimal risk. Fundamentals are healthy. The score cross-references apparent undervaluation against fundamental deterioration signals. Browse lowest value-trap stocks →

Multi-Model Methodology

13 of 13 models are active for Electromed, Inc.. Broad coverage provides high confidence. Each model applies a fundamentally different valuation philosophy. See the complete methodology →

According to the CirclFi Deep Alpha Valuation Engine, Electromed, Inc. scores 9.4 out of 10 on our 32-signal quality assessment, a elite rating that ranks among the highest-quality businesses in our coverage universe. The QOC score synthesizes profitability margins, revenue growth reliability, debt management, and capital allocation into a single metric designed to separate durable businesses from statistically cheap ones.

The gap between the most bullish and bearish model spans +329.2% — demonstrating why single-model analysis is dangerous. Browse all stocks with 13-model coverage →

Data Sources & Confidence

Every ELMD valuation is built from SEC EDGAR XBRL filings — 700+ standardized financial tags. Macroeconomic context from FRED calibrates discount rates, while GDELT news sentiment feeds into our Sentiment SOTP model. All pipelines run daily. Read the complete data methodology →

Across ELMD's 13 active models, average confidence is 48%. Lower confidence may reflect limited history or high volatility.

CirclFi's output is a research starting point, not a buy/sell signal. All data updates daily. Read the full methodology →

This analysis is produced by the CirclFi Valuation Engine using quantitative models applied to SEC EDGAR filings, public market feeds, and FRED macroeconomic indicators. It is not financial advice.

Read the full investment analysis: Should You Buy Electromed, Inc. Stock in 2026? →

Bull case, bear case, risk factors & peer comparison — updated daily

Which Similar Electromedical & Electrotherapeutic Apparatus Stocks Should You Also Analyze?

8 related Electromedical & Electrotherapeutic Apparatus stocks with 13-model coverage

INMDInMode Ltd.QOC 9.9LIVNLivaNova PLCQOC 9.1CNMDCONMED CorporationQOC 8.9ITGRInteger Holdings CorporationQOC 8.3MDTMedtronic plc.QOC 8.1TMDXTransMedics Group, Inc.QOC 8.0AXGNAxoGen, Inc.QOC 7.9CBLLCeriBell, Inc.QOC 7.2

Read investment analysis: INMD · LIVN · CNMD · ITGR · MDT

Frequently Asked Questions About Electromed, Inc.

What is Electromed, Inc.'s intrinsic value in 2026?

Based on CirclFi's 13-model analysis, Electromed, Inc. (ELMD) has multiple fair value estimates. The Bayesian DCF model runs 10,000 Monte Carlo simulations with jump-diffusion to estimate intrinsic value at $10.81. The Quality of Company score is 9.4/10 across 32 fundamental signals. All models use SEC EDGAR filings updated daily. See our methodology page for how each model works.

Is ELMD overvalued or undervalued right now?

At $45.92, 1 of 13 active models suggest ELMD may be undervalued, while 12 indicate potential overvaluation. The assessment depends on which methodology best fits Electromed, Inc.'s business model in Electromedical & Electrotherapeutic Apparatus.

What does a Quality of Company score of 9.4 mean for ELMD?

Electromed, Inc.'s QOC of 9.4/10 reflects 32 fundamental signals: profitability margins, revenue growth consistency, balance sheet leverage, free cash flow generation, and capital allocation efficiency. Scores above 7 indicate strong fundamentals and disciplined management.

How many valuation models does CirclFi run on ELMD?

CirclFi analyzes ELMD with 13 institutional-grade models daily: Bayesian DCF (Monte Carlo + jump-diffusion), EPV (Greenwald zero-growth), EROIC Spread (McKinsey reinvestment), First Chicago (3-scenario), Markov DDM (regime-switching), ML-RIV (machine learning residual income), Dynamic NAV (asset-based), PWERM (option-theoretic), Regime Cross-Sectional (relative), Sentiment SOTP (hybrid), CUCE Ensemble (meta-model), FTNN Topology (neural network), and RCMH-DCF (conditional regime). Currently 13 of 13 are active for this stock. Read the full methodology →

Is ELMD a value trap in 2026?

Electromed, Inc.'s Value Trap score is 22/100 (SAFE). This low score indicates the current valuation is not artificially depressed by fundamental deterioration, suggesting genuine opportunity rather than a trap. Browse stocks by value-trap risk →

You’ve done the research. Don’t stop at half the picture.

Stop collecting opinions. Let 13 mathematical frameworks give you clarity on ELMD.

Unlock All 13 Fair Values — $39/mo

Cancel anytime · Less than a cup of coffee · Instant access